Sangamo Therapeutics, Inc. (0R1D.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 07:13PM BST
| Previous close | 0.6620 |
| Open | 0.6798 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.6798 - 1.1350 |
| 52-week range | 0.2900 - 2.1105 |
| Volume | |
| Avg. volume | 47,193 |
| Market cap | 108.816M |
| Beta (5Y monthly) | 1.23 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.2130 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireSangamo Therapeutics Reports on Pfizer’s Announcement of Positive Topline Results From Phase 3 Trial of Hemophilia A Gene Therapy Candidate
RICHMOND, Calif., July 24, 2024--SANGAMO THERAPEUTICS REPORTS ON PFIZER’S ANNOUNCEMENT OF POSITIVE TOPLINE RESULTS FROM PHASE 3 TRIAL OF HEMOPHILIA A GENE THERAPY CANDIDATE
ZacksSarepta Therapeutics (SRPT) Soars 30.1%: Is Further Upside Left in the Stock?
Sarepta Therapeutics (SRPT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Simply Wall St.We Think Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) CEO Compensation Package Needs To Be Put Under A Microscope
Key Insights Sangamo Therapeutics will host its Annual General Meeting on 4th of June Salary of US$716.4k is part of...
© 2024 Yahoo. All rights reserved.